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ASYMPTOMATIC INFECTION OF THE HUMAN IMMUNODEFI-
CIENCY VIRUS 
by Kini berly L. Booke 
Advancements in modern medical technology seemed to have virtually wiped out the 
threat of worldwide infectious disease epidemics. By the early 1980' s, however, scientific 
communities around the globe began to gather evidence that would quickly shatter the 
earlier conceptions that we had effectively won the battle against infectious diseases. 
The isolation of the human immunodeficiency virus (HIV) in 1985 brought the threat of 
an infectious disease epidemic back to the forefront throughout the world and spurred a 
massive effort by scientific communities to understand the virus and its ability to spread, 
with the hope of gaining control over the epidemic. 
The human immunodeficiency virus (HIV) is a retrovirus that attacks the immune 
system, specifically cells expressing the CD4 receptor such as T helper cells. This attack 
on the immune system eventually leads to severe immune suppression and causes a per-
son to become open to life-threatening opportunistic infections. Suppression of the im-
mune system by HIV results in a condition called acquired immune deficiency syndrome 
(AIDS), and it is from AIDS, not the virus itself, that the infected person dies. 
HIV is passed from person to person primarily through sexual contact and/or IV 
drug use. Once infected with HIV, a person may remain asymptomatic for many years. 
This period of asymptomatic infection is a major cause for the rapid and silent spread of 
HIV throughout the world. Thus, a major concern of researchers is the ability of HIV to 
"hide" from the immune system. How does HIV effectively avoid attack and destruction 
from the immune system, and what triggers the shift from a latent unproductive viral 
state to a state of active viral production? An understanding of these questions could 
lead to the development of vaccines and treatments that would provide immeasurable 
benefit to both those people already infected and others at risk of infection. 
In order to understand the mechanisms of HIV latency, it is first necessary to under-
stand the molecular aspects of the virus, specifically its structure and life cycle. When 
HIV is passed from person to person through body fluid contact, the virus will come in 
contact with the immune cells of the newly infected person. The use of a host cell is ab-
solutely necessary for viral replication and survival. The virus consists of envelope pro-
teins, glycoproteins called gpl20 and gp41. The gpl20 protein protrudes out from the 
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viral membrane and binds to target cells that exhibit a CD4 molecule on the membrane 
surface. Binding of gpl20 to the CD4 receptor results in a conformational change that 
allows the gp41 protein to become exposed. The gp41 protein attaches to the host mem-
brane, and the two membranes fuse together (1). The virus core, which consists of the 
viral genetic material, is then injected into the host cell. With successful entry into the 
host cell, the life cycle of HIV can begin. 
The first step of the HIV life cycle rests on the ability of the virus to use reverse tran-
scriptase to convert the viral genetic information encoded in the viral RNA to a comple-
mentary DNA strand. The RNA template is destroyed in unison with reverse transcrip-
tion of the RNA to DNA. DNA polymerase is used to make the second copy of the 
DNA strand (1). The double stranded DNA consists of redundant DNA sequences at 
each end of the DNA strand, which are referred to as long terminal repeats (LTR's) (2). 
The DNA is spliced into the host genome by the action of the enzyme integrase. The in-
corporated viral DNA (provirus) can then be replicated along with the host's DNA and 
can either remain latent within the host's genome or begin assembly of new viral par-
ticles. 
If the virus is activated to produce new viral particles, then sequences within the 
L TR' s regulate the host cell enzymes in such a way that transcription of the provirus to 
RNA and activation of the viral genes occurs. The RNA directs the synthesis of new 
virions (1). The regulatory genes of the virus~tat, rev and nef ~regulate their own ex-
pression and the expression of the structural genes. Tat is a positive regulator and trig-
gers the other genes to become activated or "turned on." Rev is a differential regulator 
and triggers structural gene expression while suppressing all other genes. Nef is a nega-
tive regulating gene and suppresses the action of other genes. It is important to under-
stand that latency and activation of cellular components are precisely controlled and con-
nected. If cellular activation does not occur, then the regulatory proteins, especially the 
positive regulator tat, are prevented from directing assembly of new viral particles, and 
the virus remains latent (2). 
In order to completely discuss the concept of latency, it is first necessary to define 
what is meant by the term. A latent infection is characterized by the integration of provi-
ral DNA into the host genome so that periods lacking viral expression exist (2). Latent 
infections should be distinguished from productive persistent infections which can occur 
in three different states. A steady state infection refers to viral resistance to cell death 
which results from an established equilibrium between the virus and the cell. A carrier 
state infection refers to resistance that may be a result of cell type, defective viral forms, 
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or cell cycle. lntracytoplasmic persistence is an infection that results from ineffective vi-
ral production despite viral spread from cell to cell (2). 
A resting state form of HIV latency occurs when the virus integrates into a host cell 
that is in the G 0 phase. This phase lacks all of the activation and proliferation factors 
required for cell replication (2). Bednarik and Folks (2) have found that HIV tends to 
resist integration into a host genome when it is in the G 0 phase, but if it does become in-
tegrated into a host cell at this phase, reverse transcription will occur only incompletely. 
Thus, a cell may become infected, but it will serve primarily as a storage space for the 
virus until an activation signal is encountered and viral replication can continue. The ac-
tivation signals may come from specific antigens, antibodies, mitogens, or cytokines 
binding to receptors on the cell surface (2). 
Latent HIV infection may occur in different states of viral expression, all of which 
could be induced into the active viral state according to Bednarik and Folks (2). They 
identified five different forms of viral infection. Type I viral expression results from an 
extrachromosomal form of HIV expression where reverse transcription is incomplete. 
Type II refers to a wild type form of HIV which is capable of full expression but is 
uninduced. Type III is also a wild type form of HIV but is latent due to viral regulation 
that results from incomplete production of regulatory proteins. Undetectable or sub-de-
tectable levels of RNA or proteins characterize type IV viral expression. Type V viral 
expression represents the complete or absolute latency, and viral expression is most 
likely controlled by cellular factors. 
Latency may also be a result of differences or variations from cell to cell (2). 
Bednarik and Folks (2) have found that under uninduced viral conditions, the viral ge-
nome exists almost exclusively in the full length state. In this form of latency, the CD4 
receptor molecules remain expressed on the outside of the host cell membrane. It is only 
when the cell is activated with cytokines that the cell will express viral antigens. 
Bednarik and Folks (2) have proposed six models of transcriptional repression of the 
proviral DNA. These models include: 1) cellular or viral repressor DNA-binding pro-
teins; 2) chromatin conformation; 3) DNA hyper-methylation; 4) pre-integrative viral 
species; 5) mediation of transcriptional transactivation by cellular nuclear transcription 
factors; 6) HIV regulatory proteins. The cellular or viral repressor DNA-binding pro-
tein model suggests that a repressor may bind to sites of initiation along the long terminal 
repeats. Binding to the initiation site would result in structural restrictions that prevent 
transcriptional elements from binding and, therefore, transcription from occurring. 
Bednarik and Folks (2) do not elaborate on or present a mechanism for the chromatin 
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conformation model. Chromatin is a nucleic acid-protein complex which is found in 
chromosomes (3). I speculate that during DNA replication, when the chromatin begins 
supercoiling and becomes more dense, the initiation sites, as in the repressor model, be-
come blocked and prevent transcription. 
According to Bednarik and Folks (2), gene expression and control is regulated pri-
marily by the methylation of cytosine to 5-methylcytosine in mammalian DNA. This 
mechanism has also been detectable in the retrovirus, murine leukemia virus (MuLV). 
Inactivation of transcription in MuLV can be achieved when the LTR becomes hyper-
methylated, following integration into host chromosomal DNA. Suppression of tran-
scription could also be reversed after treatment with mitogens or DNA methylation an-
tagonists (2). Based on this information as well as other previous studies on hyper-me-
thylation, Bednarik and Folks (2) suggest that the provirus may become integrated in a 
region of the host's DNA that is hyper-methylated. If factors that reverse the methyla-
tion processes are introduced, then the barriers against transcription are removed, the 
viral regulatory proteins can begin to accumulate, and initiation of viral production oc-
curs. 
The HIV regulatory protein nef is a negative regulator of transcription and replica-
tion (1). Guy et al. (4) found that the nef gene down-regulates the DNA binding factor, 
Factor Ai, which belongs to a group of cellular activation factors. They also found that 
factors affecting nef, such as mutations, will result in an alteration of viral production. 
Viral production is increased with the expression of rev, which acts as a down regulator 
of nef (4). Therefore, viral production can be controlled by factors that affect both rev 
and nef, and they can potentially induce a switch between a state of latency and viral 
transcription (4). Malim and Cullen (5) have found that productive viral infection can 
only occur if a critical level of rev is expressed. When rev protein is at low levels, the rev 
gene is almost completely non-functioning, and this may be a cause for latent infection 
(5). 
Kato et al. (6) have found a cellular negative regulatory protein (LBP-1) that inter-
acts with the HIV promoter region that includes the TATA element necessary for tran-
scription. The binding site on the promoter region consists of a low affinity site (site I) 
and a high affinity site (site II). At high concentrations of LBP-1, both site I and site II 
are covered by LBP-1, whereas at low concentrations only site I is covered. According 
to Kato et al. (6), binding to site I resulted in increased transcription, while binding to 
site II resulted in suppressed transcription. Therefore, LBP-1 's binding specificity could 
act as a regulator of transcription, which may have implications for latency. 
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The pre-integrative viral species model refers to the process of incomplete reverse 
transcription. Cells in this state maintain this form of HIV in a non-integrated state until 
HIV is stimulated by cellular activators (2). Bednarik and Folks (2) also noted that this 
non-integrated DNA is unstable but is abundant because of continual reinfection. 
Kalebic et al. (7) examined the effects of glutathione (GSH), glutathione ester 
(GSE), and N-acetylcysteine (NAC) on HIV expression, using a monocytic Ul cell line. 
U 1 cells exhibit low levels of viral expression and can be activated or suppressed by pro-
viding the appropriate stimuli. According to Kalebic et al. (7), transcriptional activation 
can be induced by factors such as phorbol 12-myristate 13-acetate (PMA), tumor necro-
sis factor (TNF-_), and interleukin 6 (IL-6). They also found that GSH, GSE, and 
NAC could produce a suppressive effect in induced cells. Their results indicate that the 
level of TNF-_ in the blood plasma of AI OS patients is increased with an associated de-
crease in GSH. Therefore, levels of transcriptional suppressor factors are decreased in 
patients with AIDS, which may indicate that these factors play an important r~le during 
latency by effectively suppressing activation factors. Pomerantz et al. (8) noted that al-
most no RNA is produced in infected cells during the early stages of infection, but when 
induced by factors such as PMA the infected cell quickly progressed to later stages of 
infection with significant viral production and RNA synthesis. The control of transcrip-
tion is due to the levels of Rev which code for singly-spliced mRNA's or multiply-spliced 
mRNA's. The multiply-spliced mRNA's code for regulatory proteins, and the singly-
spliced mRNA's code for structural proteins (8). If the singly-spliced mRNA's are not 
available to code for structural proteins, then synthesis of new viral particles cannot oc-
cur, and the virus must remain latent. Thus, mediation of the transcription inducers 
could provide a treatment with, perhaps, a remission into latency for AIDS patients. 
Now that the mechanisms for HIV latency have been explored, it is worthwhile to 
examine the effects of latency on the HIV infected person. "Asymptomatic" is not an ac-
curate phrase to use when discussing the latent period of HIV infection. This period of 
infection can be identified by a number of signs and symptoms that affect the living qual-
ity of each infected person. If a person in the latent phase of infection, which may last 
(on the average) ten years, is compared to a person with full blown AIDS, the former 
does indeed appear "asymptomatic." The person is free from life-threatening opportunis-
tic infections, his immune system is not severely suppressed, and his life continues as 
normally as possible. 
Hoover et al. (9) examined the signs and symptoms of asymptomatic infection in ho-
mosexual men for the multicenter AIDS cohort study. At six month intervals, 916 ho-
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mosexual/bisexual men who were HIV seropositive and AIDS free were evaluated by 
personal interviews, physical examinations, and laboratory tests. Also enrolled as con-
trols were 2, 161 HIV seronegative men. Mean values were calculated for comparison at 
visit 3 and visit 7. The seropositive subjects reported 0.2 more symptoms, including fe-
ver, thrush, headaches, new rashes, and unusual coughs compared to the seronegative 
subjects. Skin rashes showed an increase of four percent for the seropositive men versus 
the seronegative men, indicating that this condition may be highly correlated with HIV 
infection in the asymptomatic stages (9). Hemoglobin levels and T-helper cell levels 
were significantly lower in visit 7 compared to visit 3 for the seropositive subjects. 
Seropositive subjects also had a lower body mass index at both visits than the 
seronegative controls. Hoover et al. (9) noted that diarrhea and skin discolorations did 
not differ between the two groups, which may indicate that these symptoms are more in-
dicative of the later stages of infection, including AIDS related complex. Based on the 
results indicating that seropositive men report 0.20 more symptoms, it was calculated 
that these men see an increase of 5.6 days per year of discomfort. 
Hoover et al. (9) postulated that the increase in reported headaches for seropositive 
asymptomatic men may be due to the effect of HIV on the central nervous system. 
Sinforiani et al. (10) specifically examined cognitive abnormalities in relation to disease 
progression in asymptomatic seropositive subjects. In this study, forty-one 
asymptomatic seropositive homosexual/bisexual men from an age range of 19-60 and an 
educational level range from 3-17 years, and forty-one seronegative men with a similar 
age and educational level range, underwent neuropsychological evaluations. The evalua-
tion included nine tests which assessed short term verbal memory and attention, logic 
memory, visual reproduction, non-verbal intelligence and visuo-spatial abilities, logic 
abilities, visuo-motor and attentive functions, selective attention, word fluency, and 
visuo-perceptive abilities. Sinforiani et al. (10) found that there was no significant differ-
ence in cognitive, neurological, and neuropsychological abilities between the 
asymptomatic seropositive group and the control group. One drawback of this study is 
that it was a cross-sectional study, and a change in a person's cognitive ability over time 
was not examined. I was unable to find a longitudinal study on the effects of HIV on the 
CNS that follows a person from diagnosis of HIV and the asymptomatic stage through 
AIDS, but I believe that such a study would provide a great d~al of insight into this area 
of research. 
Lifson et al. (11) examined long term HIV infection in asymptomatic homosexual/ 
bisexual men, in order to determine immunologic and virologic characteristics. The 
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study examined twenty-four men who had been seropositive for up to 10.5 years but had 
not yet developed AIDS, AIDS related complex, or low CD4+ levels (non-progressors). 
Two control groups were also used, men with AIDS and men seronegative for HIV. 
The study found that the non-progressors had increased levels of -2-microglobulin com-
pared to the seronegative controls but levels below that of the AI OS controls. -2-
microglobulin levels are used as a predictor of HIV progression, and the increased levels 
in non-progressors indicates that the immune system is affected in some manner. The 
increased levels may indicate viral replication, although maintained at very low levels, or 
it may represent another mechanism controlling viral replication so that a latency state is 
preserved. The non-progressors also differed from both control groups in that their 
CD8+ levels were higher. Lifson et al. (11) cited a number of studies to help explain the 
elevated CD8+ counts. One study found that elevated CD8+ counts signified develop-
ment toward AIDS and declines in CD4 + levels, while the other study indicated that el-
evated CD8+ counts inhibited HIV replication. The latter is supported by the work of 
Lifson et al. (11) which presents data that implies that the elevated CD8+ levels serve as 
a suppressor and may help to control viral replication. 
Based on the clinical differences between asymptomatic HIV patients and AIDS pa-
tients, it is not unreasonable to postulate that the virus may be both biologically and ge-
netically different in the two stages of infection. Balachandran et al. (12) explored this 
premise and found that viral isolates from asymptomatic patients were clearly different 
from the isolates taken from AIDS patients. Both phytohemagglutinin (PHA) stimu-
lated peripheral blood lymphocytes (PBL) and H9 cells were not infected with 
asymptomatic isolates. Isolates from asymptomatic men, who remained asymptomatic 
for two to three years, were tested in a longitudinal study and found to be incapable of 
infecting H9 cells. On the other hand, a longitudinal study of asymptomatic men who 
later developed AIDS showed that they were later able to infect H9 cells. This change in 
the ability of the isolates to infect H9 cells may be caused by infection of an HIV strain 
that is more biologically and genetically similar to the strain found in AIDS patients, or 
the individuals may have been more susceptible to a more virulent strain of HIV (12). 
Balachandran et al. (12) also found that AIDS isolates were more likely to induce syncy-
tia than the asymptomatic isolates. The ability of the AI OS isolates to replicate was 
found to be much greater than in the asymptomatic isolates, and AIDS isolates produced 
higher levels of viral DNA than the asymptomatic isolates. 
Genetically, AIDS isolates and asymptomatic isolates differ in the restriction site 
Bg/II in the gag region of the genome, according to Balachandran et al. (12). In their 
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study of the Bg/11 restriction site, six out of six asymptomatic isolates contained the site, 
while only twelve of the twenty-eight AIDS isolates contained the site. Although the 
significance of this site is unknown, it remains important to the study of HIV. 
Although CD4 + cell counts remain the dominant predictor of disease progression for 
HIV and serve as the defining factor for separation of AIDS patients from HIV infected 
individuals, this is not the only method for prediction of disease progression. 
Dehydroepiandrosterone (DHEA) is a steroid hormone that enhances synthesis of 
interleukin-2 (IL-2) by activated T cells (13). Patients infected with HIV exhibit de-
creased levels of IL-2. In a study of DHEA as a predictor for progression, Mulder et al. 
(13) found there is a decline in DHEA levels from the seroconversion for HIV to the de-
velopment of AIDS. In addition to DHEA, anti-pl7 antibody levels can be used as a 
predictor of disease progression. P 17 is an envelope protein that is displayed on the sur-
face of infected cells so that antibodies are produced against it (1). Anti-pl7 antibody 
tends to have a neutralizing effect against HIV, and Choudhury et al. (14) found that in 
a study of fifty-six asymptomatic subjects and forty-six AIDS subjects, the number of 
subjects not exhibiting anti-pl7 antibodies increased as the disease progressed from 
CDC stage II/III to CDC stage IV. They also noted that the asymptomatic patients ex-
hibited a strong antibody response, while the symptomatic patients exhibited little or no 
antibody response, and concluded that the decline of anti-pl7 antibodies favors advance-
ment towards AIDS. 
All of the studies presented thus far have used homosexual/bisexual men as their 
subjects, but Deschamps et al. (15) examined the effects of childbearing on women with 
HIV. They conducted an observational study of forty-four women who became preg-
nant or were pregnant during the study. All women were seropositive and 
asymptomatic patients from Haiti. The study found that pregnant women developed 
signs and symptoms of HIV before nonpregnant women. Of the nonpregnant women, 
nineteen percent developed AIDS during the study, while thirty-two percent of the 
pregnant women developed AIDS. Deschamps et al. also found, however, that twenty-
seven percent of the nonpregnant women died from AIDS during the study, as opposed 
to fifteen percent of the pregnant women. Thus, pregnancy was not found to reduce 
AI OS free survival time. Based on the results, the study theorized that pregnancy in-
creased the rate of depletion of CD4 + cells but the effects of pregnancy still remain un-
clear. 
Many different models and mechanisms for latency have been presented as well as a 
variety of studies on asymptomatic infection. This paper only touches the surface of the 
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